Constraint-induced movement therapy (CIMT) is one of the best studied treatments for hemiplegic cerebral palsy (CP), which is one of the most common types of CP and is estimated to affect 1 per every 1000 children.1,2  Therefore, optimizing the delivery of and access to CIMT has the potential for a broad-reaching and significant impact in pediatric care.

CIMT is composed of 2 key components: (1) restraint of the unaffected upper limb, and (2) an intensive structured therapy program. The pathophysiologic rationale behind CIMT is that developmental disregard of the weaker arm can further limit its function. Multiple small studies in children using functional MRI have suggested that CIMT can lead to enlargement of the injured sensorimotor cortex, which is associated with improvement in motor skills in the affected limb in children with hemiplegic CP.

CIMT focuses...

You do not currently have access to this content.